Rixensart, Belgium

Loic Le Gourrierec

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Loic Le Gourrierec. Retrieved from https://idiyas.com/inventor/loic-le-gourrierec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Loic Le Gourrierec: Innovator in Adjuvant Manufacturing

Introduction

Loic Le Gourrierec is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of adjuvants used in vaccines. His innovative approach has led to advancements that enhance the efficacy of immunological responses.

Latest Patents

Loic Le Gourrierec holds a patent for "Methods for manufacturing an adjuvant." This invention relates to compositions and methods for manufacturing an adjuvant comprising a saponin using a microfluidic device. The patent highlights the importance of utilizing advanced technology to improve vaccine formulations.

Career Highlights

Loic is currently associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His work focuses on developing new methods and technologies that contribute to vaccine development and public health.

Collaborations

Throughout his career, Loic has collaborated with esteemed colleagues such as Pol Harvengt and Philippe Jehoulet. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Loic Le Gourrierec's contributions to the field of adjuvant manufacturing exemplify the impact of innovative thinking in biotechnology. His work continues to influence vaccine development and improve health outcomes globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…